<DOC>
	<DOCNO>NCT02286258</DOCNO>
	<brief_summary>The purpose study validate comparison reference method ( inuline ) two novel non-radioactive biomarkers glomerular filtration rate ( GFR ) measurement chronic-kidney disease ( CKD ) patient healthy volunteer : Calcium-EDTA Gd-DOTA .</brief_summary>
	<brief_title>Validation New Markers Glomerular Filtration Rate : Dota Gadolinium Calcium EDTA ( MultiGFR )</brief_title>
	<detailed_description>Research estimation measurement renal function greatly stimulate international concept chronic kidney disease ( CKD ) classification stage severity base level glomerular filtration rate ( GFR ) ( National Kidney Foundation KDOQI ANAES 2002 , KDIGO conference 2005 ) , development recommendation clinical practice accord stage . Many effort focus validation new formula estimate GFR endogenous marker . Nevertheless , performance formula limit large inter individual variability , require many case use GFR measurement use exogenous tracer ( extreme anthropometric characteristic , abnormal production endogenous tracer , potential kidney donor , dose adjustment , nephrotoxicity monitoring… ) . The use GFR measurement burden lack availability due methodological , biological regulatory ( radioactive tracer ) constraint . That 's need exist new validated tracer accessible easy use . Moreover , difference measurement technique : single injection tracer concentration equilibrium obtain continuous infusion ; plasma urinary clearance . Two new tracer GFR measurement offer validation : Gd-DOTA Calcium-EDTA . Gd-DOTA macrocyclic paramagnetic contrast product , measure use ELISA type immunoassay . Although widely use radiology high dos use GFR measurement multi-GFR study , Gd-DOTA never involve systemic nephrogenic fibrosis case ( ProFinest study ) . Calcium-EDTA use many year chelation heavy metal . Recently , colorimetric assay Calcium-EDTA measurement develop . Gd-DOTA Calcium-EDTA clearance GFR measurement compare inuline clearance healthy volunteer ( 25 new tracer ) CKD patient ( 150 new tracer ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Edetic Acid</mesh_term>
	<mesh_term>Pentetic Acid</mesh_term>
	<mesh_term>Gadolinium 1,4,7,10-tetraazacyclododecane-N , N ' , N '' , N '' '-tetraacetate</mesh_term>
	<criteria>Patients : male female without pregnancy age : 1875 stable chronic kidney disease stag 1 4 ( MDRD KDIGO 2005 ) , estimate GFR &gt; 15 mL/min/1.73m² clinical GFR measurement indication kidney transplantation allergic acute disease lead acute change GFR heavy metal poison ( treat ) gadolinium contrast agent previous month Healthy volunteer : Inclusion criterion male , 1835 year old weight : 60100 kg , BMI 1827 kg/m² estimate GFR &gt; 90 mL/min/1.73 m² ( MDRD ) acute diseases previous 7 day Exclusion criterion : uronephrological disease ( past present ) nephrotoxic drug chronic use previous 2 month allergic systemic disease ( acute chronic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Inulin</keyword>
	<keyword>Ca-EDTA</keyword>
	<keyword>Gd-DOTA</keyword>
	<keyword>Chronic kidney disease</keyword>
	<keyword>glomerular filtration rate measurement</keyword>
</DOC>